Resultados da busca - Javier Pinilla‐Ibarz

Refinar Resultados
  1. 1
    Signaling Networks Associated with BCR–ABL–Dependent Transformation

    Signaling Networks Associated with BCR–ABL–Dependent Transformation por Lori Hazlehurst, Nadine N. Bewry, Rajesh R. Nair, Javier Pinilla‐Ibarz

    Publicado em 2009
    Obter o texto integral Obter o texto integral
    Revisão
    Salvar na lista
    Na minha lista:
  2. 2
    Molecular Action of Lenalidomide in Lymphocytes and Hematologic Malignancies

    Molecular Action of Lenalidomide in Lymphocytes and Hematologic Malignancies por Jessica M. McDaniel, Javier Pinilla‐Ibarz, Pearlie K. Epling‐Burnette

    Publicado em 2012
    Obter o texto integral Obter o texto integral
    Artigo
    Salvar na lista
    Na minha lista:
  3. 3
    Impact of mitochondrial metabolism on T-cell dysfunction in chronic lymphocytic leukemia

    Impact of mitochondrial metabolism on T-cell dysfunction in chronic lymphocytic leukemia por Wael Gamal, Melanie Mediavilla-Varela, Vishaal Kunta, Eva Sahakian, Javier Pinilla‐Ibarz

    Publicado em 2025
    Obter o texto integral
    Revisão
    Salvar na lista
    Na minha lista:
  4. 4
    Stat3 contributes to resistance toward BCR-ABL inhibitors in a bone marrow microenvironment model of drug resistance

    Stat3 contributes to resistance toward BCR-ABL inhibitors in a bone marrow microenvironment model of drug resistance por Nadine N. Bewry, Rajesh R. Nair, Michael F. Emmons, David Boulware, Javier Pinilla‐Ibarz, Lori A. Hazlehurst

    Publicado em 2008
    Obter o texto integral Obter o texto integral
    Artigo
    Salvar na lista
    Na minha lista:
  5. 5
    Pleural Effusion in Dasatinib-Treated Patients With Chronic Myeloid Leukemia in Chronic Phase: Identification and Management

    Pleural Effusion in Dasatinib-Treated Patients With Chronic Myeloid Leukemia in Chronic Phase: Identification and Management por Jorge E. Cortés, Carlos A. Jiménez, Michael J. Mauro, Alex Geyer, Javier Pinilla‐Ibarz, Benjamin D. Smith

    Publicado em 2016
    Obter o texto integral Obter o texto integral
    Revisão
    Salvar na lista
    Na minha lista:
  6. 6
    <scp>WT</scp>1 vaccination in <scp>AML</scp> and <scp>MDS</scp>: A pilot trial with synthetic analog peptides

    <scp>WT</scp>1 vaccination in <scp>AML</scp> and <scp>MDS</scp>: A pilot trial with synthetic analog peptides por Jason Brayer, Jeffrey E. Lancet, John J. Powers, Alan F. List, Lodovico Balducci, Rami S. Komrokji, Javier Pinilla‐Ibarz

    Publicado em 2015
    Obter o texto integral
    Artigo
    Salvar na lista
    Na minha lista:
  7. 7
    Side-effects profile and outcomes of ponatinib in the treatment of chronic myeloid leukemia

    Side-effects profile and outcomes of ponatinib in the treatment of chronic myeloid leukemia por Onyee Chan, Chetasi Talati, Leidy Isenalumhe, Samantha Shams, Lisa Nodzon, Michael G. Fradley, Kendra Sweet, Javier Pinilla‐Ibarz

    Publicado em 2020
    Obter o texto integral
    Artigo
    Salvar na lista
    Na minha lista:
  8. 8
    A multivalent bcr-abl fusion peptide vaccination trial in patients with chronic myeloid leukemia

    A multivalent bcr-abl fusion peptide vaccination trial in patients with chronic myeloid leukemia por Kathleen N. S. Cathcart, Javier Pinilla‐Ibarz, Tatyana Korontsvit, Joseph E. Schwartz, Victoriya Zakhaleva, Esperanza B. Papadopoulos, David A. Scheinberg

    Publicado em 2003
    Obter o texto integral Obter o texto integral
    Artigo
    Salvar na lista
    Na minha lista:
  9. 9
    Peptide Epitopes from the Wilms' Tumor 1 Oncoprotein Stimulate CD4+ and CD8+ T Cells That Recognize and Kill Human Malignant Mesothelioma Tumor Cells

    Peptide Epitopes from the Wilms' Tumor 1 Oncoprotein Stimulate CD4+ and CD8+ T Cells That Recognize and Kill Human Malignant Mesothelioma Tumor Cells por Rena J. May, Tao Dao, Javier Pinilla‐Ibarz, Tatyana Korontsvit, Victoriya Zakhaleva, Rong H. Zhang, P. Maslak, David A. Scheinberg

    Publicado em 2007
    Obter o texto integral Obter o texto integral
    Artigo
    Salvar na lista
    Na minha lista:
  10. 10
    Phase 1 study of INNO‐406, a dual Abl/Lyn kinase inhibitor, in Philadelphia chromosome‐positive leukemias after imatinib resistance or intolerance

    Phase 1 study of INNO‐406, a dual Abl/Lyn kinase inhibitor, in Philadelphia chromosome‐positive leukemias after imatinib resistance or intolerance por Hagop M. Kantarjian, Phillipp le Coutre, Jorge E. Cortés, Javier Pinilla‐Ibarz, Arnon Nagler, Andreas Hochhaus, Shinya Kimura, Oliver G. Ottmann

    Publicado em 2010
    Obter o texto integral
    Artigo
    Salvar na lista
    Na minha lista:
  11. 11
    A phase I clinical trial of ruxolitinib in combination with nilotinib in chronic myeloid leukemia patients with molecular evidence of disease

    A phase I clinical trial of ruxolitinib in combination with nilotinib in chronic myeloid leukemia patients with molecular evidence of disease por Kendra Sweet, Lori Hazlehurst, Eva Sahakian, John J. Powers, Lisa Nodzon, Fadi Kayali, Kelly A. Hyland, Ashley Nelson, Javier Pinilla‐Ibarz

    Publicado em 2018
    Obter o texto integral
    Artigo
    Salvar na lista
    Na minha lista:
  12. 12
    Preliminary Results of Voice (Virtual Opinions poll Independent Centered on CLL patients’ Experience): A Global Survey to Assess the Disease-Specific Knowledge and Perspectives of Real-World Patients with CLL

    Preliminary Results of Voice (Virtual Opinions poll Independent Centered on CLL patients’ Experience): A Global Survey to Assess the Disease-Specific Knowledge and Perspectives of... por Constantine S. Tam, Javier Pinilla Ibarz, Volkan Karakuş, Catherine Moura, Miguel Arturo Pavlovsky, Fernando Nicolás Piotrowsky, Martin Šimkovič, Andrew Smith, Stephan Stilgenbauer

    Publicado em 2022
    Obter o texto integral
    Artigo
    Salvar na lista
    Na minha lista:
  13. 13
    Inhibition of ER stress–associated IRE-1/XBP-1 pathway reduces leukemic cell survival

    Inhibition of ER stress–associated IRE-1/XBP-1 pathway reduces leukemic cell survival por Chih-Hang Anthony Tang, Sujeewa Ranatunga, Crystina L. Kriss, Christopher L. Cubitt, Jianguo Tao, Javier Pinilla‐Ibarz, Juan R. Del Valle, Chih‐Chi Andrew Hu

    Publicado em 2014
    Obter o texto integral Obter o texto integral
    Artigo
    Salvar na lista
    Na minha lista:
  14. 14
    NCCN Task Force Report: Tyrosine Kinase Inhibitor Therapy Selection in the Management of Patients With Chronic Myelogenous Leukemia

    NCCN Task Force Report: Tyrosine Kinase Inhibitor Therapy Selection in the Management of Patients With Chronic Myelogenous Leukemia por Susan O’Brien, Ellin Berman, Joseph O. Moore, Javier Pinilla‐Ibarz, Jerald P. Radich, Paul J. Shami, Benjamin D. Smith, David S. Snyder, Hema Sundar, Moshe Talpaz, Meir Wetzler

    Publicado em 2011
    Obter o texto integral Obter o texto integral
    Artigo
    Salvar na lista
    Na minha lista:
  15. 15
    The histone deacetylase HDAC11 regulates the expression of interleukin 10 and immune tolerance

    The histone deacetylase HDAC11 regulates the expression of interleukin 10 and immune tolerance por Alejandro Villagra, Fengdong Cheng, Hongwei Wang, Ildelfonso Suarez, Michelle Glozak, Michelle Maurin, Danny Nguyen, Kenneth L. Wright, Peter Atadja, Kapil N. Bhalla, Javier Pinilla‐Ibarz, Edward Seto, Eduardo M. Sotomayor

    Publicado em 2008
    Obter o texto integral
    Artigo
    Salvar na lista
    Na minha lista:
  16. 16
    Quality of life outcomes in patients with chronic myeloid leukemia treated with tyrosine kinase inhibitors: a controlled comparison

    Quality of life outcomes in patients with chronic myeloid leukemia treated with tyrosine kinase inhibitors: a controlled comparison por Kristin M. Phillips, Javier Pinilla‐Ibarz, Eduardo M. Sotomayor, Morgan Lee, Heather Jim, Brent J. Small, Lubomir Sokol, Jeffrey E. Lancet, Sara Tinsley, Kendra Sweet, Rami S. Komrokji, Paul B. Jacobsen

    Publicado em 2012
    Obter o texto integral Obter o texto integral
    Artigo
    Salvar na lista
    Na minha lista:
  17. 17
    Validation of the revised International Prognostic Scoring System in treated patients with myelodysplastic syndromes

    Validation of the revised International Prognostic Scoring System in treated patients with myelodysplastic syndromes por Asmita Mishra, Maria Corrales‐Yepez, Najla Al Ali, Mohamed A. Kharfan‐Dabaja, Eric Padron, Ling Zhang, Pearlie K. Epling‐Burnette, Javier Pinilla‐Ibarz, Jeffrey E. Lancet, Alan F. List, Rami S. Komrokji

    Publicado em 2013
    Obter o texto integral Obter o texto integral
    Artigo
    Salvar na lista
    Na minha lista:
  18. 18
    PB1945: PATIENT PERSPECTIVES ON CLL TREATMENT SIDE EFFECTS: A SUB-ANALYSIS OF THE VOICE SURVEY

    PB1945: PATIENT PERSPECTIVES ON CLL TREATMENT SIDE EFFECTS: A SUB-ANALYSIS OF THE VOICE SURVEY por Constantine S. Tam, Javier Pinilla‐Ibarz, Volkan Karakuş, Miguel Arturo Pavlovsky, Stephan Stilgebauer, Martin Šimkovič, Ana Cristina Fenili, Miguel Augusto Miroli, Carolina García-Castillo, Kathryn Huntley, Catherine Moura, Fernando Piotrowski, Mervat Mattar

    Publicado em 2023
    Obter o texto integral
    Artigo
    Salvar na lista
    Na minha lista:
  19. 19
    Results of VOICE: a global survey of disease-specific knowledge and perspectives of real-world patients with CLL

    Results of VOICE: a global survey of disease-specific knowledge and perspectives of real-world patients with CLL por Constantine S. Tam, Javier Pinilla‐Ibarz, Carolina García-Castillo, Ana Cristina Fenili, Kathryn Huntley, Volkan Karakuş, Mervat Mattar, Miguel Augusto Miroli, Catherine Moura, Miguel Arturo Pavlovsky, Fernando Piotrowski, Martin Šimkovič, Stephan Stilgenbauer

    Publicado em 2023
    Obter o texto integral Obter o texto integral
    Artigo
    Salvar na lista
    Na minha lista:
  20. 20
    Minimal cross-intolerance with nilotinib in patients with chronic myeloid leukemia in chronic or accelerated phase who are intolerant to imatinib

    Minimal cross-intolerance with nilotinib in patients with chronic myeloid leukemia in chronic or accelerated phase who are intolerant to imatinib por Jorge E. Cortés, Andreas Hochhaus, Philipp D. le Coutre, Gianantonio Rosti, Javier Pinilla‐Ibarz, Elias Jabbour, Kathryn Gillis, Richard C. Woodman, Rick E. Blakesley, Francis J. Giles, Hagop M. Kantarjian, Michele Baccarani

    Publicado em 2011
    Obter o texto integral
    Artigo
    Salvar na lista
    Na minha lista:

Ferramentas de busca: